Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1LifeFirst Pharma

02 1Om Pharmaceutical Industries

03 1Sigmak Lifesciences

04 1Sms Lifesciences

05 1Vidgas Science & Technologies

PharmaCompass

01

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

3-Amino-4-pyrazolecarboxamide hemisulfate

CAS Number : 27511-79-1

End Use API :

About the Company : We believe in attaining the highest levels of customer satisfaction and social welfare with the philosophy of keeping first things first. Our systematic interventions keeping abreast of...

blank

02

arrow
PharmaVenue
Not Confirmed

3-AMINO-4-PYRAZOLECARBOXAMIDE HEMISULFATE

CAS Number : CAS-27511-79-1

End Use API :

About the Company : OM Pharmaceutical Industries is one of the established pharmaceutical company in India, which is engaged in manufacturing of Active Pharmaceutical Ingredients (API) and intermediates. W...

blank

03

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

3- Amino-4-pyrazole carboxamide Hemisulfate

CAS Number : 27511-79-1

End Use API :

About the Company : Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutical APIs & Fine Chemicals. We excel in Contract Manufacturing, covering a wide spe...

blank

04

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

5-amino-1H-pyrazole-4-carboxamide hemisulphate

CAS Number : 27511-79-1

End Use API :

About the Company : SMS Lifesciences is a global player in APIs/Intermediates manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a s...

blank

05

arrow
PharmaVenue
Not Confirmed

3-Amino-4-pyrazolecarboxamide hemisulfate salt

CAS Number : 27511-79-1

End Use API :

About the Company : VIDGAS aims to provide our pharmaceutical, Bio pharma, Agrochemical, Food and Fine chemical customers with the highest quality SFC and HPLC purification and isolation solutions that mar...

blank